Independence Bank of Kentucky’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.56K Sell
45
-40
-47% -$6.88K ﹤0.01% 512
2026
Q1
$14.4K Hold
85
﹤0.01% 502
2025
Q4
$14.3K Hold
85
﹤0.01% 512
2025
Q3
$12.3K Sell
85
-15
-15% -$2.05K ﹤0.01% 522
2025
Q2
$12.7K Sell
100
-45
-31% -$5.52K ﹤0.01% 511
2025
Q1
$18.5K Buy
145
+50
+53% +$6.78K ﹤0.01% 472
2024
Q4
$12.6K Hold
95
﹤0.01% 502
2024
Q3
$13.8K Hold
95
﹤0.01% 461
2024
Q2
$13K Sell
95
-59
-38% -$7.88K ﹤0.01% 437
2024
Q1
$21.1K Sell
154
-6
-4% -$819 0.01% 387
2023
Q4
$21.7K Sell
160
-50
-24% -$6.1K 0.01% 368
2023
Q3
$25.7K Sell
210
-35
-14% -$4.45K 0.01% 335
2023
Q2
$31.1K Hold
245
0.01% 322
2023
Q1
$31.6K Hold
245
0.01% 293
2022
Q4
$32K Hold
245
0.01% 286
2022
Q3
$29K Buy
245
+35
+17% +$4.35K 0.01% 278
2022
Q2
$25K Buy
210
+115
+121% +$13.7K 0.01% 298
2022
Q1
$12K Buy
95
+45
+90% +$5.86K ﹤0.01% 339
2021
Q4
$8K Buy
+50
New +$7.74K ﹤0.01% 348

Other funds holding IBB

Independence Bank of Kentucky's IBB Position: Q2 2026 in Review

Independence Bank of Kentucky reduced its iShares Biotechnology ETF (IBB) stake by 47% in Q2 2026, selling an estimated $6.88K and leaving 45 shares worth $8.56K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Independence Bank of Kentucky first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $32K in Q4 2022. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Independence Bank of Kentucky held 45 shares of iShares Biotechnology ETF worth $8.56K as of Q2 2026.
  • Independence Bank of Kentucky sold 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
  • iShares Biotechnology ETF made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #512 holding.
  • Independence Bank of Kentucky first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • Independence Bank of Kentucky's iShares Biotechnology ETF position peaked at $32K in Q4 2022.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.